IR vs STRO
Ingersoll Rand Inc (IR) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
IR currently screens at market cap $28.27B and trailing P/E 48.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the IR and STRO stock pages for the full models.
Not investment advice.